Medical Devices Startups

Amadix develops blood-based diagnostic tests for early cancer detection before symptoms appear. The company focuses on non-invasive liquid biopsy technology to identify tumors years earlier than traditional methods.

1 investor

Ambient Clinical develops Sepsis DART, a clinical monitoring platform that integrates with Epic, Cerner, and Meditech to identify sepsis patients and track SEP-1 bundle compliance in real time across care transitions. The system provides automated detection, bundle compliance monitoring, and targeted escalations to improve sepsis management in hospitals.

1 investor

Ambra Health provides a cloud-based medical imaging suite that connects physicians and care staff to imaging information across the patient journey. It serves radiology groups, hospitals, and health systems, and is now part of Intelerad, a GE HealthCare company.

1 investor

AMCG develops an AI-powered cardiac diagnostic imaging platform for early diagnosis. The company provides medical device manufacturing and diagnostic solutions using artificial intelligence and big data analytics.

1 investor

Amedes Group organizes continuing education events, webinars, and training seminars for physicians and medical practice teams across Germany, with content delivered by internal medical experts.

1 investor

American Gene Technologies develops gene therapy treatments for serious diseases including HIV, phenylketonuria, and liver cancer, using a proprietary platform approach designed to accelerate drug development and reduce costs.

1 investor

American Pathology Partners (AP2) was a laboratory and pathology services company; it has sold all of its operations, including UniPath, Alliance Health Sciences, Cytology Associates, Palm Beach Pathology, and Eastern Carolina Pathology, and no longer provides laboratory or pathology services.

1 investor

Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.

1 investor

AMI (Acute Medical Innovation) develops medical device hardware and software-as-a-medical-device (SaMD) to redefine stethoscope-based auscultation, including the Cardio-EGG (AMI-SSS01 series phonocardiography device) that simultaneously captures heart sounds and ECG. Using deep learning and other machine learning models trained on clinical data, it builds diagnostic-assist tools for heart disease and a telemedicine support system called "Cloud Choshin" for sharing heart sound, ECG, and analysis results.

1 investor

Amino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.

1 investor

AMLo Biosciences develops prognostic and companion diagnostic tests for cancer patients, initially focusing on melanoma and oropharyngeal squamous cell carcinoma. The company translates cancer biomarker research into tests designed to stratify patient risk and optimize treatment allocation.

1 investor

Amnova Biotech develops injectable therapies derived from amniotic biomaterials to promote heart regeneration following ischemic injury. The company targets cardiac regenerative medicine and is advancing its lead therapies from preclinical validation toward clinical application.

1 investor

Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants. The medical device company, based in the Netherlands and Wales, is preparing for US commercial launch in the revision arthroplasty market.

1 investor

Amoy Diagnostics develops molecular diagnostic test kits for cancer detection, including PCR, IHC, FISH, and next-generation sequencing products that detect gene mutations such as PIK3CA, KRAS, NRAS, BRAF, and IDH1, as well as microsatellite instability. Its products serve clinical and oncology diagnostics and include related nucleic acid extraction reagents and instruments.

1 investor

Amphastar Pharmaceuticals manufactures and distributes generic and branded pharmaceutical products, including injectable medications, inhalation aerosols, and emergency treatments for medical professionals and patients in the United States.

1 investor

Ampliconyx designs and manufactures high-performance fiber lasers and gain modules for semiconductor processing, medical devices, LiDAR systems, defense, aerospace, and research applications. The company offers both standard off-the-shelf laser products and custom-engineered solutions optimized for demanding photonic applications.

1 investor

Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.

1 investor

Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.

1 investor

Amplitude VC creates, builds, and grows companies specializing in precision medicine to transform patient outcomes. The firm invests from ideation through patient care, focusing on innovations in human health.

1 investor

Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.

1 investor

AMR Bio develops XF-73, a first-in-class topical antimicrobial candidate in Phase 3 trials designed to prevent post-surgical infections, with the lead program targeting pre-operative decolonization in surgical settings. The company also advances dermal formulations for severe wound and skin infections.

1 investor

Amsel Medical develops minimally invasive vessel occlusion devices for vascular surgery, trauma care, and interventional procedures. The company's products, including the SCureClamp iDOT and SCureTOTM, are designed to occlude blood vessels for applications ranging from venous disease treatment to combat hemorrhage control.

1 investor

AMT Medical develops the Elana Anastomotic System, a medical device using a clip and laser catheter to create the distal anastomosis connecting a graft to the coronary artery in coronary bypass (CABG) surgery. The device targets cardiac surgeons and care teams and supports open, off-pump, and minimally invasive procedures including MIDCAB and robotic-assisted TECAB techniques.

1 investor

AMW GmbH is a specialty pharmaceutical company that develops biodegradable drug delivery systems for controlled release of medications, with production facilities in Germany. It has two approved implant products, Goserelin and Leuprorelin, distributed worldwide through local and global pharmaceutical partners.

1 investor